Quantum technologies are rapidly moving from theoretical promise to real-world application, with quantum sensing emerging as a particularly exciting frontier for healthcare. This webinar will introduce ABHI members to the evolving landscape of quantum sensing, exploring how these technologies could transform the way we detect, measure, and understand disease across clinical pathways.

Focusing on quantum sensing for medical imaging and quantum-enhanced in vitro diagnostics (IVDs), the session will provide an accessible overview of how these approaches differ from conventional technologies, and where they may offer step-changes in sensitivity, precision, and early detection. Attendees will gain insight into current research, emerging use cases, and the potential impact on patient outcomes and healthcare delivery.

The session will also consider how quantum sensing technologies are likely to navigate regulatory, evaluation, and adoption pathways, helping industry understand what to expect as these innovations move closer to commercialisation. This includes reflections on evidence generation, integration into existing systems, and the role of collaboration between academia, industry, and healthcare providers.

Delivered by experts from Q-BIOMED at University College London, this webinar will offer a valuable opportunity for HealthTech companies to build awareness, ask questions, and explore how they can engage with this emerging field and the Q-BIOMED multidisciplinary team, which continue to expand its industrial partnerships.

Whether you are working in diagnostics, imaging, or broader innovation strategy, this session will provide practical insights into a technology area set to shape the future of healthcare.

REGISTER HERE.